AIG
SPRO icon

American International Group’s Spero Therapeutics SPRO Stock Holding History

American International Group’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,015
Closed -$105K – 3250
2022
Q1 		$105K Sell
12,015
-845
-7% -$8.66K ﹤0.01% 2576
2021
Q4 		$206K Sell
12,860
-385
-3% -$6.12K ﹤0.01% 2352
2021
Q3 		$244K Sell
13,245
-314
-2% -$5.04K ﹤0.01% 2309
2021
Q2 		$189 Buy
13,559
+1,643
+14% +$23K ﹤0.01% 2540
2021
Q1 		$175 Buy
11,916
+31
+0.3% +$546 ﹤0.01% 2435
2020
Q4 		$230 Buy
11,885
+3,045
+34% +$47.5K ﹤0.01% 2205
2020
Q3 		$99K Buy
8,840
+38
+0.4% +$450 ﹤0.01% 2547
2020
Q2 		$119K Buy
8,802
+1,176
+15% +$13.2K ﹤0.01% 2419
2020
Q1 		$62K Buy
7,626
+623
+9% +$5.49K ﹤0.01% 2577
2019
Q4 		$67K Buy
7,003
+115
+2% +$1.24K ﹤0.01% 2807
2019
Q3 		$73K Buy
6,888
+374
+6% +$3.94K ﹤0.01% 2759
2019
Q2 		$75K Buy
6,514
+1,430
+28% +$17.2K ﹤0.01% 2822
2019
Q1 		$65K Sell
5,084
-464
-8% -$4.92K ﹤0.01% 2789
2018
Q4 		$34K Sell
5,548
-43
-0.8% -$348 ﹤0.01% 2965
2018
Q3 		$59K Buy
5,591
+1,246
+29% +$14.5K ﹤0.01% 3032
2018
Q2 		$64K Buy
4,345
+488
+13% +$6.24K ﹤0.01% 2939
2018
Q1 		$55K Sell
3,857
-206
-5% -$2.5K ﹤0.01% 2881
2017
Q4 		$48K Buy
+4,063
New +$49.9K ﹤0.01% 2951

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

American International Group's SPRO Position: Q2 2022 in Review

American International Group sold out of Spero Therapeutics (SPRO) in Q2 2022, closing a stake of 12,015 shares — an estimated $105K sold.

American International Group first reported a position in SPRO in Q4 2017 and held it in 18 quarters. The position peaked at $244K in Q3 2021. 79 funds tracked by Wall St. Rank hold SPRO as of Q2 2022.

  • American International Group reported no remaining Spero Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 12,015 Spero Therapeutics shares in Q2 2022, an estimated $105K.
  • American International Group first reported a position in Spero Therapeutics in Q4 2017 and held it in 18 quarters.
  • American International Group's Spero Therapeutics position peaked at $244K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.